This is an expanded access designed to provide access to apixaban for eligible participants.
Inclusion Criteria:
Exclusion Criteria:
Other inclusion/exclusion criteria apply
Clinical.Trials@bms.complease email:
Philadelphia, Pennsylvania 19104, United States